-transparent.png){kind=logo}
Although an aggressive form of Kaposi's sarcoma often develops in patients with the acquired immunodeficiency syndrome, most patients die due to opportunistic infections rather than the direct effects of this tumor. Because Kaposi's sarcoma has caused pulmonary dysfunction in a number of our patients, we attempted to characterize features of pulmonary dysfunction induced by Kaposi's sarcoma. In 66 patients with Kaposi's sarcoma treated between 1982 and 1984 there were 30 episodes of pulmonary dysfunction that resulted in a biopsy. Six episodes were due to pulmonary Kaposi's sarcoma alone, and 6 additional episodes were due to Kaposi's sarcoma and associated opportunistic infections. Clinical and radiologic features of pulmonary Kaposi's sarcoma an infection were indistinguishable. Pulmonary Kaposi's sarcoma could only be documented in large tissue sections available from open-lung biopsy or autopsy samples. Because chemotherapy or radiation therapy appears to provide palliation, clinicians should recognize Kaposi's sarcoma as a cause of pulmonary disease in patients with the acquired immunodeficiency syndrome.
F P Ognibene, and
R G Steis, and
A M Macher, and
L Liotta, and
E Gelmann, and
H I Pass, and
H C Lane, and
A S Fauci, and
J E Parrillo, and
H Masur
February 1983,
Lancet (London, England),
F P Ognibene, and
R G Steis, and
A M Macher, and
L Liotta, and
E Gelmann, and
H I Pass, and
H C Lane, and
A S Fauci, and
J E Parrillo, and
H Masur
June 1985,
The Western journal of medicine,
F P Ognibene, and
R G Steis, and
A M Macher, and
L Liotta, and
E Gelmann, and
H I Pass, and
H C Lane, and
A S Fauci, and
J E Parrillo, and
H Masur
February 1985,
Journal of the Royal Society of Medicine,
F P Ognibene, and
R G Steis, and
A M Macher, and
L Liotta, and
E Gelmann, and
H I Pass, and
H C Lane, and
A S Fauci, and
J E Parrillo, and
H Masur
January 1984,
The New Zealand medical journal,
F P Ognibene, and
R G Steis, and
A M Macher, and
L Liotta, and
E Gelmann, and
H I Pass, and
H C Lane, and
A S Fauci, and
J E Parrillo, and
H Masur
May 1986,
The Medical clinics of North America,
F P Ognibene, and
R G Steis, and
A M Macher, and
L Liotta, and
E Gelmann, and
H I Pass, and
H C Lane, and
A S Fauci, and
J E Parrillo, and
H Masur
June 1988,
Infectious disease clinics of North America,
F P Ognibene, and
R G Steis, and
A M Macher, and
L Liotta, and
E Gelmann, and
H I Pass, and
H C Lane, and
A S Fauci, and
J E Parrillo, and
H Masur
February 1997,
Nihon Kyobu Shikkan Gakkai zasshi,
F P Ognibene, and
R G Steis, and
A M Macher, and
L Liotta, and
E Gelmann, and
H I Pass, and
H C Lane, and
A S Fauci, and
J E Parrillo, and
H Masur
September 1995,
Mayo Clinic proceedings,
F P Ognibene, and
R G Steis, and
A M Macher, and
L Liotta, and
E Gelmann, and
H I Pass, and
H C Lane, and
A S Fauci, and
J E Parrillo, and
H Masur
February 1984,
The Ohio State medical journal,
F P Ognibene, and
R G Steis, and
A M Macher, and
L Liotta, and
E Gelmann, and
H I Pass, and
H C Lane, and
A S Fauci, and
J E Parrillo, and
H Masur
September 1984,
International journal of dermatology,
